158 related articles for article (PubMed ID: 23146748)
1. Decreased levels of AKR1B1 and AKR1B10 in cancerous endometrium compared to adjacent non-cancerous tissue.
Hevir N; Sinkovec J; Lanišnik Rižner T
Chem Biol Interact; 2013 Feb; 202(1-3):226-33. PubMed ID: 23146748
[TBL] [Abstract][Full Text] [Related]
2. STAR and AKR1B10 are down-regulated in high-grade endometrial cancer.
Sinreih M; Štupar S; Čemažar L; Verdenik I; Frković Grazio S; Smrkolj Š; Rižner TL
J Steroid Biochem Mol Biol; 2017 Jul; 171():43-53. PubMed ID: 28232277
[TBL] [Abstract][Full Text] [Related]
3. Opposing roles of the aldo-keto reductases AKR1B1 and AKR1B10 in colorectal cancer.
Taskoparan B; Seza EG; Demirkol S; Tuncer S; Stefek M; Gure AO; Banerjee S
Cell Oncol (Dordr); 2017 Dec; 40(6):563-578. PubMed ID: 28929377
[TBL] [Abstract][Full Text] [Related]
4. The human aldose reductase AKR1B1 qualifies as the primary prostaglandin F synthase in the endometrium.
Bresson E; Boucher-Kovalik S; Chapdelaine P; Madore E; Harvey N; Laberge PY; Leboeuf M; Fortier MA
J Clin Endocrinol Metab; 2011 Jan; 96(1):210-9. PubMed ID: 20943776
[TBL] [Abstract][Full Text] [Related]
5. Altered expression of genes involved in progesterone biosynthesis, metabolism and action in endometrial cancer.
Sinreih M; Hevir N; Rižner TL
Chem Biol Interact; 2013 Feb; 202(1-3):210-7. PubMed ID: 23200943
[TBL] [Abstract][Full Text] [Related]
6. AKR1B1 and AKR1B10 as Prognostic Biomarkers of Endometrioid Endometrial Carcinomas.
Hojnik M; Frković Grazio S; Verdenik I; Rižner TL
Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298614
[TBL] [Abstract][Full Text] [Related]
7. Identification and expression analysis of the aldo-ketoreductase1-B10 gene in primary malignant liver tumours.
Heringlake S; Hofdmann M; Fiebeler A; Manns MP; Schmiegel W; Tannapfel A
J Hepatol; 2010 Feb; 52(2):220-7. PubMed ID: 20036025
[TBL] [Abstract][Full Text] [Related]
8. Expression of AKR1B1, AKR1C3 and other genes of prostaglandin F2α biosynthesis and action in ovarian endometriosis tissue and in model cell lines.
Sinreih M; Anko M; Kene NH; Kocbek V; Rižner TL
Chem Biol Interact; 2015 Jun; 234():320-31. PubMed ID: 25446850
[TBL] [Abstract][Full Text] [Related]
9. [Expression of aldo-keto reductase family 1 member B10 in gastric cancer tissues and its clinical significance].
Yao HB; Xu Y; Chen LG; Guan TP; Ma YY; Tao HQ; Shao QS
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Feb; 16(2):183-7. PubMed ID: 23446484
[TBL] [Abstract][Full Text] [Related]
10. Disturbed expression of phase I and phase II estrogen-metabolizing enzymes in endometrial cancer: lower levels of CYP1B1 and increased expression of S-COMT.
Hevir N; Sinkovec J; Rižner TL
Mol Cell Endocrinol; 2011 Jan; 331(1):158-67. PubMed ID: 20887769
[TBL] [Abstract][Full Text] [Related]
11. [Downregulation of AKR1B10 gene expression in colorectal cancer].
Kropotova ES; Tychko RA; Zinov'eva OL; Zyrianova AF; Khankin SL; Cherkes VL; Aliev VA; Beresten' SF; Oparina NIu; Mashkova TD
Mol Biol (Mosk); 2010; 44(2):243-50. PubMed ID: 20586184
[TBL] [Abstract][Full Text] [Related]
12. Overexpression and enhanced specific activity of aldoketo reductases (AKR1B1 & AKR1B10) in human breast cancers.
Reddy KA; Kumar PU; Srinivasulu M; Triveni B; Sharada K; Ismail A; Reddy GB
Breast; 2017 Feb; 31():137-143. PubMed ID: 27855345
[TBL] [Abstract][Full Text] [Related]
13. Proteasome inhibitors MG-132 and bortezomib induce AKR1C1, AKR1C3, AKR1B1, and AKR1B10 in human colon cancer cell lines SW-480 and HT-29.
Ebert B; Kisiela M; Wsól V; Maser E
Chem Biol Interact; 2011 May; 191(1-3):239-49. PubMed ID: 21215737
[TBL] [Abstract][Full Text] [Related]
14. Generation of human endometrial knockout cell lines with the CRISPR/Cas9 system confirms the prostaglandin F2α synthase activity of aldo-ketoreductase 1B1.
Lacroix Pépin N; Chapdelaine P; Rodriguez Y; Tremblay JP; Fortier MA
Mol Hum Reprod; 2014 Jul; 20(7):650-63. PubMed ID: 24674991
[TBL] [Abstract][Full Text] [Related]
15. Murine aldo-keto reductase family 1 subfamily B: identification of AKR1B8 as an ortholog of human AKR1B10.
Joshi A; Rajput S; Wang C; Ma J; Cao D
Biol Chem; 2010 Dec; 391(12):1371-8. PubMed ID: 21087085
[TBL] [Abstract][Full Text] [Related]
16. Multiple promoters of catechol-O-methyltransferase gene are selectively inactivated by CpG hypermethylation in endometrial cancer.
Sasaki M; Kaneuchi M; Sakuragi N; Dahiya R
Cancer Res; 2003 Jun; 63(12):3101-6. PubMed ID: 12810635
[TBL] [Abstract][Full Text] [Related]
17. Disturbance of circadian gene expression in endometrial cancer: detection by real-time quantitative RT-PCR.
Shih HC; Choo KB; Chang TJ; Yang MY; Shih MC; Yeh KT; Liu TC; Lin SF; Chang JG
Oncol Rep; 2005 Dec; 14(6):1533-8. PubMed ID: 16273251
[TBL] [Abstract][Full Text] [Related]
18. Inhibitor selectivity between aldo-keto reductase superfamily members AKR1B10 and AKR1B1: role of Trp112 (Trp111).
Zhang L; Zhang H; Zhao Y; Li Z; Chen S; Zhai J; Chen Y; Xie W; Wang Z; Li Q; Zheng X; Hu X
FEBS Lett; 2013 Nov; 587(22):3681-6. PubMed ID: 24100137
[TBL] [Abstract][Full Text] [Related]
19. Aldo-Keto Reductases as Early Biomarkers of Hepatocellular Carcinoma: A Comparison Between Animal Models and Human HCC.
Torres-Mena JE; Salazar-Villegas KN; Sánchez-Rodríguez R; López-Gabiño B; Del Pozo-Yauner L; Arellanes-Robledo J; Villa-Treviño S; Gutiérrez-Nava MA; Pérez-Carreón JI
Dig Dis Sci; 2018 Apr; 63(4):934-944. PubMed ID: 29383608
[TBL] [Abstract][Full Text] [Related]
20. Selective inhibition of the tumor marker aldo-keto reductase family member 1B10 by oleanolic acid.
Takemura M; Endo S; Matsunaga T; Soda M; Zhao HT; El-Kabbani O; Tajima K; Iinuma M; Hara A
J Nat Prod; 2011 May; 74(5):1201-6. PubMed ID: 21561086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
